For most people, the first meeting with an oncologist happens only after something has already gone wrong.
Rethinking When Oncology Begins
Most people think of oncology as a specialty reserved for treatment.
Current cancer screening guidelines have saved countless lives and remain essential. But they were designed for populations, not individuals.
The introduction happens in an exam room, often on one of the worst days of a person’s life. A scan has revealed something concerning. A biopsy has confirmed a diagnosis. Questions outnumber answers, and urgency has replaced choice.
That sequence feels normal because it is how modern cancer care has been built. Oncology has historically been designed to diagnose, stage, and treat cancer after it has already developed.
But there is an important question few people stop to ask:
Why does our relationship with an oncologist begin only after cancer becomes a possibility?
For heart disease, we do not wait for a heart attack before involving a cardiologist. For diabetes, we monitor risk years before complications develop. Across medicine, specialists are increasingly focused on prevention and early intervention.
Cancer has largely remained the exception.
PreOncology is the medical discipline dedicated to detecting, interpreting, and intervening at the earliest stage at which cancer can be definitively identified. It exists to change that timeline.
Rethinking When Oncology Begins
Most people think of oncology as a specialty reserved for treatment.
In reality, medical oncologists are uniquely trained to understand how cancers develop, how risk changes over time, which surveillance strategies are most appropriate, and when a finding deserves immediate attention versus careful observation.
Those are valuable perspectives long before someone is diagnosed with cancer.
Yet under today’s healthcare model, most people never benefit from that expertise until they are already facing one of the most stressful moments of their lives.
There is an opportunity to bring oncology expertise upstream, while there is still time to reduce uncertainty, personalize surveillance, and potentially change the outcome altogether.
Why One-Size-Fits-All Screening Has Limits
Current cancer screening guidelines have saved countless lives and remain essential. But they were designed for populations, not individuals.
Two healthy 48-year-olds may receive the same screening recommendations despite having dramatically different genetics, family histories, environmental exposures, and biological risk factors.
Population guidelines must simplify risk in order to work at scale. Individual patients are rarely that simple. Genetics, inherited predisposition, lifestyle, environmental exposures, prior medical history, and emerging biological signals all contribute to a person’s unique risk profile.
That creates an opportunity to think differently about cancer prevention and early detection. Rather than relying solely on generalized screening schedules, care can begin with a personalized understanding of an individual’s risk and evolve over time as new clinical information becomes available.
Cancer Biology Begins Before Cancer Can Be Seen
Most people think cancer begins when a tumor appears on a scan. In reality, the biological processes that lead to cancer often begin years earlier.
Conventional oncology staging begins at Stage 0, when pathology is already localized and a lesion is visible. But cancer does not begin there. Converging evidence from circulating tumor DNA, radiomics, immune profiling, and multi-omic biomarkers demonstrates that malignant biology is active well before any lesion can be seen.
PreOncology defines that window as Stage Alpha: a biologically active, preclinical state in which cancer is detectable, but no tumor has yet localized. It is the earliest point at which interception is possible, and where prevention, immune optimization, and individualized surveillance have the greatest potential to alter the outcome.
What Proactive Oncology Access Looks Like
PreOncology delivers the first medical-grade, oncologist-led cancer prevention and early detection program built to identify cancer at Stage Alpha, so that cure, not lifelong treatment, becomes the expected outcome. The program is initiated through your primary care physician and overseen directly by board-certified medical oncologists, and it is powered by the Stage Alpha Operating System™ (patent pending), which uses predictive modeling to calculate your individual risk across the most common cancers.
The program begins with the Stage Alpha Assessment, a three-part process that establishes the foundation of your personalized prevention plan.
The first step is a single blood draw, producing an oncology-specific genomic analysis more comprehensive than standard hereditary cancer risk testing. This test is performed once and reinterpreted continuously as the underlying science advances, meaning your risk profile evolves along with the field rather than staying frozen at the moment of your original test.
The second step is a precision risk assessment, a structured clinical intake that captures personal and family history, lifestyle factors, and other clinically relevant details. This information, combined with your genomic analysis, builds a risk profile specific to you rather than to a population average.
The third step is an initial consultation with your Prevention Care Team, a dedicated session in which an oncology nurse practitioner and genetic counselor walk through your personalized risk profile and individualized prevention plan. A full report from the meeting is shared with you and your primary care physician through the PreOncology Platform, so everyone involved in your care is working from the same information.
From there, you may be recommended for an ongoing surveillance program that matches your individual cancer risk. All recommended testing (MRI, advanced blood-based testing, multi-cancer early detection testing, and more) is included and coordinated as part of the ongoing surveillance program, so you are never left to manage fragmented testing or interpret a result on your own.
What Changes for You
Under the traditional population-based care model, an individual’s connection to oncology begins at the point of crisis. Decisions are made under time pressure, often without the benefit of a prevention history or a baseline understanding of that individual’s biology. When cancer care is moved upstream, that relationship begins years earlier, when there is still time to act with clarity rather than urgency.
This also changes what oversight looks like when something does need a closer look. If a result raises a question, it does not fall to the member to interpret it alone. It is reviewed by the Signal Board, a team of board-certified medical oncologists who evaluate the finding and provide a clear path forward.
Deciding If a Cancer Prevention and Early Detection Program Is Right for You
That kind of standard, oncology expertise present before it is needed rather than summoned only once it is, is not something most people have access to today. Deciding whether it is right for you comes down to a simpler question: do you want an ongoing, personalized understanding of your cancer risk, rather than relying solely on standard, population-based screening.
The PreOncology Program is physician-supervised, initiated through your primary care physician, and works alongside your existing care team rather than around it. It is not a wellness program or a one-time screening test. Routine screenings such as mammograms, colonoscopies, and other guideline-based recommendations remain an essential part of your care.
If you have been wondering whether an earlier relationship with oncology expertise makes sense for you, the first step is a conversation with your primary care physician. They can help you understand whether the program fits your individual risk profile and health history.
The best time to have an oncologist is before you have cancer. The PreOncology Program was built to make that possible.
Interested in taking the Stage Alpha Assessment? Fill out the form and we will contact your primary care physician on your behalf to discuss the program in more detail.
Cancer Prevention Program Frequently Asked Questions
Is the PreOncology Program a substitute for my regular cancer screenings?
No. The program is built on top of your existing care, not in place of it. Your primary care physician remains central to the process, and standard screenings such as mammograms and colonoscopies continue as recommended. The PreOncology Program adds a layer of individualized risk assessment and oncologist oversight that conventional screening was not designed to provide.
What does the Stage Alpha Assessment involve, and how long does it take?
The assessment has three steps: a single blood draw for oncology specific genomic analysis, a structured clinical intake covering personal and family history, and an initial consultation with your Prevention Care Team to review your results. The Stage Alpha Assessment takes three to four weeks to complete, depending on how quickly you decide to move through the process.
Who is a good candidate for the program?
The program is designed for individuals who want a personalized, ongoing understanding of their cancer risk rather than relying solely on standard, population-based screening guidelines. The Stage Alpha Assessment is available to individuals age 18 and older. Individuals age 35 and older are more likely to be recommended for ongoing surveillance through Baseline, Core, or Advanced, based on their individual risk profile.
How is my risk profile determined, and what happens if something abnormal is found?
Your risk profile is built from your genomic analysis combined with your personal and family history and lifestyle factors, calculated through the Stage Alpha Operating System. If a result needs a closer look, it is reviewed by the Signal Board, a team of board-certified medical oncologists who evaluate the finding and provide a clear path forward. Members are never left to interpret a result on their own.
Does my primary care physician stay involved, or does PreOncology take over my care?
Your primary care physician stays involved throughout. The program is initiated through your primary care physician, and all results and recommendations from your Prevention Care Team are shared directly with them.
